Publicaciones en las que colabora con Jesús Manuel Peregrina García (14)

2024

  1. Multivalent carbohydrates systems as antiviral therapueutics

    7th Iberian Carbohydrate Meeting: Abstract book

  2. Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses

    JACS Au, Vol. 4, Núm. 1, pp. 150-163

2023

  1. APPLICATION OF AUGMENTED REALITY IN CHEMISTRY TEACHING

    XXXIX Reunión Bienal de Química RSEQ. Libro de Abstracts

  2. Design of cancer vaccines based on muc1-like glycopeptides and mesoporous silica nanoparticles

    XXXIX Reunión Bienal de la Sociedad Española de Química - RSEQ - Zaragoza 2023. Abstracts Book

  3. La Realidad Aumentada en la Enseñanza de la Química: Implementación en el Aula y Evaluación de su Impacto.

    La Realidad Aumentada en la Enseñanza de la Química: Implementación en el Aula y Evaluación de su Impacto.

  4. Methyl-to-Ethyl Replacement Makes the Difference: Structure-Guided Design of a New Cancer Vaccine Based on a Tn An-gen Surrogate

    VI RSEQ Chemical Biology Group Meeting - ChemBio VI

  5. SYNTHESIS OF CANCER VACCINES INCORPORATING MUC1-LIKE GLYCOPEPTIDES AND MESOPOROUS SILICA NANOPARTICLES

    XIII Jornadas de Carbohidratos (Spanish Carbohydrate Meeting). Book of Abstracts

2022

  1. Desing of cancer vaccines based on MUC1-Like Glycopeptides Containing Non-Natural Amino Acids

    XXXVIII Reunión Bienal de la Real Sociedad Española de Química - RSEQ 2022 (Abstracts book)

  2. Structure-based Design of Anti-cancer Vaccines: The Significance of Antigen Presentation to Boost the Immune Response

    Current Medicinal Chemistry, Vol. 29, Núm. 7, pp. 1258-1270

2021

  1. Design of cancer vaccines based on the use of non-natural glycopeptides with β-amino acids

    XVII Simposio de Investigadores Jóvenes RSEQ. Libro de resúmenes

  2. Diseño de vacunas terapéuticas contra el cáncer basadas en glicopéptidos no naturales

    XI Jornada de Química CISQ

2020

  1. Synthesis, conformational analysis and: In vivo assays of an anti-cancer vaccine that features an unnatural antigen based on an sp2-iminosugar fragment

    Chemical Science, Vol. 11, Núm. 15, pp. 3996-4006

2018

  1. The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies inpatients with cancer

    29th International Carbohydrate Symposium - ICS2018

2017

  1. The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

    Journal of the American Chemical Society, Vol. 139, Núm. 50, pp. 18255-18261